A Randomized Trial of Adjunct mHealth Abstinence Reinforcement With Transdermal Nicotine and Counseling for Smoking Cessation

被引:21
|
作者
Alessi, Sheila M. [1 ,2 ]
Rash, Carla J.
Petry, Nancy M.
机构
[1] Univ Connecticut, Sch Med, 263 Farmington Ave, Farmington, CT 06030 USA
[2] Univ Connecticut, Calhoun Cardiol Ctr, Behav Hlth, 263 Farmington Ave, Farmington, CT 06030 USA
基金
美国国家卫生研究院;
关键词
VOUCHER-BASED INCENTIVES; CONTINGENCY MANAGEMENT; SUBSTANCE USE; FINANCIAL INCENTIVES; CIGARETTE-SMOKING; PROMOTE ABSTINENCE; INTERVENTIONS; SMOKERS; DEPENDENCE; THERAPY;
D O I
10.1093/ntr/ntw155
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Abstinence reinforcement is efficacious for improving smoking treatment outcomes, but practical constraints related to the need for multiple in-person carbon monoxide (CO) breath tests daily to verify smoking abstinence have limited its use. This study tested an mHealth procedure to remotely monitor and reinforce smoking abstinence in individuals' natural environment. Methods: Eligible treatment-seeking smokers (N = 90) were randomized to (1) usual care and ecological monitoring with abstinence reinforcement (mHealth reinforcement) or (2) without reinforcement (mHealth monitoring). Usual care was 8 weeks of transdermal nicotine and twice-weekly telephone counseling. Following training, an interactive voice response system prompted participants to conduct CO tests 1-3 daily at pseudorandom times (7 am to 10 pm) for 4 weeks. When prompted, participants used a study cell phone and CO monitor to complete a CO self-test, video record the process, and submit videos using multimedia messaging. mHealth reinforcement participants could earn prizes for smoking-negative on-time CO tests. The interactive voice response generated preliminary earnings immediately. Earnings were finalized by comparing video records against participants' self-reports. Results: mHealth reinforcement was associated with a greater proportion of smoking-negative CO tests, longest duration of prolonged abstinence, and point-prevalence abstinence during the monitoring/reinforcement phase compared to mHealth monitoring (p < .01, d = 0.8-1.3). Follow-up (weeks 4-24) analyses indicated main effects of reinforcement on point-prevalence abstinence and proportion of days smoked (p = .05); values were comparable by week 24. Conclusions: mHealth reinforcement has short-term efficacy. Research on methods to enhance and sustain benefits is needed. Implications: This study suggests that mHealth abstinence reinforcement is efficacious and may present temporal and spatial opportunities to research, engage, and support smokers trying to quit that do not exist with conventional (not technology-based) reinforcement interventions.
引用
收藏
页码:290 / 298
页数:9
相关论文
共 50 条
  • [31] Nicotine Gum Treatment Before Smoking Cessation A Randomized Trial
    Etter, Jean-Francois
    Huguelet, Philippe
    Perneger, Thomas V.
    Cornuz, Jacques
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (11) : 1028 - 1034
  • [32] RANDOMIZED CONTROLLED TRIAL OF NASAL NICOTINE SPRAY IN SMOKING CESSATION
    SUTHERLAND, G
    STAPLETON, JA
    RUSSELL, MAH
    JARVIS, MJ
    HAJEK, P
    BELCHER, M
    FEYERABEND, C
    [J]. LANCET, 1992, 340 (8815): : 324 - 329
  • [33] Randomized Trial of Nicotine Lozenges and Phone Counseling for Smokeless Tobacco Cessation
    Severson, Herbert H.
    Danaher, Brian G.
    Ebbert, Jon O.
    van Meter, Nora
    Lichtenstein, Edward
    Widdop, Chris
    Crowley, Ryann
    Akers, Laura
    Seeley, John R.
    [J]. NICOTINE & TOBACCO RESEARCH, 2015, 17 (03) : 309 - 315
  • [35] EFFECTIVENESS OF A TRANSDERMAL NICOTINE SYSTEM IN SMOKING CESSATION STUDIES
    ABELIN, T
    EHRSAM, R
    BUHLERREICHERT, A
    IMHOF, PR
    MULLER, P
    THOMMEN, A
    VESANEN, K
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1989, 11 (03): : 205 - 214
  • [36] TRANSDERMAL NICOTINE IN SMOKING CESSATION AND INVOLVEMENT OF NONSPECIFIC INFLUENCES
    MERZ, PG
    KELLERSTANISLAWSKI, B
    HUBER, T
    WOODCOCK, BG
    RIETBROCK, N
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1993, 31 (10) : 476 - 482
  • [37] COMBINATION OF BEHAVIORAL SMOKING CESSATION WITH TRANSDERMAL NICOTINE SUBSTITUTION
    BUCHKREMER, G
    BENTS, H
    HORSTMANN, M
    OPITZ, K
    TOLLE, R
    [J]. ADDICTIVE BEHAVIORS, 1989, 14 (02) : 229 - 238
  • [38] Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial
    Heffner, Jaimee L.
    Serfozo, Edit
    Baker, Kelsey
    Gasser, Melissa
    Watson, Noreen
    Daughters, Stacey B.
    Becona, Elisardo
    McClure, Jennifer B.
    [J]. NICOTINE & TOBACCO RESEARCH, 2024,
  • [39] Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation
    Lerman, Caryn
    Tyndale, Rachel
    Patterson, Freda
    Wileyto, E. Paul
    Shields, Peter G.
    Pinto, Angela
    Benowitz, Neal
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (06) : 600 - 608
  • [40] Factors Associated with Adherence to Transdermal Nicotine Patches within a Smoking Cessation Effectiveness Trial
    Handschin, Jonnie
    Hitsman, Brian
    Blazekovic, Sonja
    Veluz-Wilkins, Anna
    Wileyto, E. Paul
    Leone, Frank T.
    Ashare, Rebecca L.
    Schnoll, Robert A.
    [J]. JOURNAL OF SMOKING CESSATION, 2018, 13 (01) : 33 - 43